In cell proliferation and colony‐forming assays, imatinib exhibited a stronger inhibitory effect on GIST cells with SHP2 knockout compared with GIST cells with intact SHP2 (Figures 6E, F and S8). This evidence concerns the gene PTPN11 and gastrointestinal stromal tumor.